Research Methodology – Oncology Biosimilar Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Oncology Biosimilar Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Oncology Biosimilar Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Number of oncology biosimilar products in the market.
- Demand and supply of oncology biosimilar products in different regions.
- Current and future potential of oncology biosimilar products in terms of revenue generation.
- Market penetration of the oncology biosimilar products.
- Competitive landscape and market share of key competitors.
- Regulatory landscape impacting the market.
- Prices of oncology biosimilar products and its impact on demand.
- Consumer behavior and preference towards oncology biosimilar products.
Key Market Indicators
- Revenue generated from oncology biosimilar products.
- Growth rate of the oncology biosimilar market.
- Market share of major players in the oncology biosimilar market.
- Product development and innovation trends in the oncology biosimilar market.
- Changes in demand and supply of oncology biosimilar products in different regions.
- Changes in regulations and its impact on the market.
Growth Trends
- Increasing prevalence of different types of cancer worldwide.
- Rising preference for affordable cancer treatment options.
- Expansion of healthcare sector in developing countries.
- Increasing research & development activities in the field of oncology biosimilar products.
- Emergence of new players and increased competition in the market.
- Growth in adoption of oncology biosimilar drugs due to their cost-effectiveness.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Oncology Biosimilar Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Oncology Biosimilar Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
